137 related articles for article (PubMed ID: 31397146)
1. Preserving the Efficacy of Glycopeptide Antibiotics during Nanoencapsulation in Liposomes.
Gonzalez Gomez A; Xu C; Hosseinidoust Z
ACS Infect Dis; 2019 Oct; 5(10):1794-1801. PubMed ID: 31397146
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of spontaneous resistance to glycopeptide antibiotics in staphylococcal populations.
Biavasco F; Montanari MP; Facinelli B; Varaldo PE
J Chemother; 1989 Jul; 1(4 Suppl):389-90. PubMed ID: 16312453
[No Abstract] [Full Text] [Related]
3. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
Nashev D; Toshkova K; Gavrilova V
Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
[TBL] [Abstract][Full Text] [Related]
4. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
Carper HT; Sullivan GW; Mandell GL
J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
[TBL] [Abstract][Full Text] [Related]
5. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M
J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
[TBL] [Abstract][Full Text] [Related]
7. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Drago L; De Vecchi E; Nicola L; Gismondo MR
BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
[TBL] [Abstract][Full Text] [Related]
9. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
[TBL] [Abstract][Full Text] [Related]
10. Glycopeptide antibiotics: from conventional molecules to new derivatives.
Van Bambeke F; Van Laethem Y; Courvalin P; Tulkens PM
Drugs; 2004; 64(9):913-36. PubMed ID: 15101783
[TBL] [Abstract][Full Text] [Related]
11. Glycopeptide resistance in Staphylococcus aureus.
Chadwick PR; Wooster SL
J Infect; 2000 May; 40(3):211-7. PubMed ID: 10908014
[No Abstract] [Full Text] [Related]
12. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
[No Abstract] [Full Text] [Related]
14. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
Harland S; Tebbs SE; Elliott TS
J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides.
Betts JW; Abdul Momin HF; Phee LM; Wareham DW
J Med Microbiol; 2018 Feb; 67(2):265-271. PubMed ID: 29300156
[TBL] [Abstract][Full Text] [Related]
16. Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin.
Onyeji CO; Nightingale CH; Marangos MN
Infection; 1994; 22(5):338-42. PubMed ID: 7843812
[TBL] [Abstract][Full Text] [Related]
17. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide.
Lopez S; Hackbarth C; Romanò G; Trias J; Jabes D; Goldstein BP
J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033
[TBL] [Abstract][Full Text] [Related]
18. Glycopeptide resistance in coagulase-negative staphylococci.
Biavasco F; Vignaroli C; Varaldo PE
Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
[TBL] [Abstract][Full Text] [Related]
19. Detecting vancomycin intermediate Staphylococcus aureus.
Commun Dis Rep CDR Wkly; 1997 Nov; 7(47):417, 20. PubMed ID: 9401190
[No Abstract] [Full Text] [Related]
20. Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus
Hobdey SE; Katahira EJ; Dockstader P; Davidson SM; Bond L; Bolz DD; Bryant AE; Stevens DL
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
